Banque Pictet & Cie’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
23,986
-14,546
-38% -$7.89M 0.08% 91
2025
Q4
$22.3M Sell
38,532
-1,732
-4% -$979K 0.13% 62
2025
Q3
$19.5M Buy
40,264
+8,408
+26% +$3.91M 0.11% 67
2025
Q2
$12.9M Sell
31,856
-35,469
-53% -$14.8M 0.09% 83
2025
Q1
$33.5M Sell
67,325
-100,636
-60% -$54.5M 0.27% 48
2024
Q4
$87.4M Sell
167,961
-17,902
-10% -$9.84M 0.58% 26
2024
Q3
$115M Sell
185,863
-3,769
-2% -$2.23M 0.87% 22
2024
Q2
$105M Sell
189,632
-5,458
-3% -$3.13M 0.95% 23
2024
Q1
$113M Sell
195,090
-5,376
-3% -$3.02M 1.06% 22
2023
Q4
$106M Sell
200,466
-19,542
-9% -$9.46M 0.88% 20
2023
Q3
$111M Sell
220,008
-20,600
-9% -$11M 1.31% 17
2023
Q2
$126M Sell
240,608
-20,255
-8% -$10.9M 1.1% 20
2023
Q1
$150M Buy
260,863
+5,892
+2% +$3.32M 1.46% 18
2022
Q4
$140M Buy
254,971
+4,894
+2% +$2.59M 1.46% 18
2022
Q3
$127M Sell
250,077
-2,782
-1% -$1.56M 1.38% 19
2022
Q2
$137K Buy
252,859
+2,624
+1% +$1.44M 1.36% 18
2022
Q1
$148M Sell
250,235
-6,674
-3% -$3.83M 1.14% 19
2021
Q4
$171M Buy
256,909
+49,810
+24% +$31.1M 1.27% 19
2021
Q3
$118M Buy
207,099
+8,572
+4% +$4.7M 1.23% 18
2021
Q2
$100M Buy
198,527
+7,488
+4% +$3.53M 1.12% 18
2021
Q1
$87.2M Sell
191,039
-5,905
-3% -$2.82M 1.12% 18
2020
Q4
$91.7M Sell
196,944
-48,037
-20% -$22.5M 1.25% 18
2020
Q3
$108M Buy
244,981
+9,668
+4% +$3.99M 1.63% 16
2020
Q2
$85.3M Buy
235,313
+6,922
+3% +$2.32M 1.43% 16
2020
Q1
$64.8M Buy
228,391
+4,653
+2% +$1.47M 1.33% 16
2019
Q4
$72.7M Buy
223,738
+9,817
+5% +$2.98M 1.26% 19
2019
Q3
$62.3M Sell
213,921
-11,626
-5% -$3.33M 1.18% 19
2019
Q2
$66.2M Sell
225,547
-8,069
-3% -$2.22M 1.22% 19
2019
Q1
$63.9M Sell
233,616
-24,530
-10% -$6.1M 1.23% 19
2018
Q4
$57.8M Sell
258,146
-73,587
-22% -$17.3M 1.18% 20
2018
Q3
$81M Buy
331,733
+24,058
+8% +$5.53M 1.5% 21
2018
Q2
$63.7M Sell
307,675
-50,032
-14% -$10.6M 1.25% 21
2018
Q1
$73.9M Sell
357,707
-18,792
-5% -$3.94M 1.55% 18
2017
Q4
$71.5M Sell
376,499
-27,788
-7% -$5.32M 1.43% 21
2017
Q3
$76.5M Buy
404,287
+16,695
+4% +$3.02M 1.73% 18
2017
Q2
$67.6M Sell
387,592
-32,454
-8% -$5.45M 1.61% 18
2017
Q1
$64.5M Sell
420,046
-78,458
-16% -$12M 1.6% 20
2016
Q4
$70.3M Sell
498,504
-62,106
-11% -$9.16M 1.81% 16
2016
Q3
$89.2M Sell
560,610
-33,016
-6% -$5.09M 2.3% 11
2016
Q2
$87.7M Sell
593,626
-175,099
-23% -$25.8M 2.34% 10
2016
Q1
$109M Buy
768,725
+13,504
+2% +$1.81M 2.84% 7
2015
Q4
$107M Buy
755,221
+19,413
+3% +$2.59M 2.89% 7
2015
Q3
$90M Buy
+735,808
New +$95.9M 2.68% 7
2015
Q2
Sell
-720,605
Closed -$96.8M 460
2015
Q1
$96.8M Buy
720,605
+48,263
+7% +$6.22M 2.52% 8
2014
Q4
$84.2M Buy
672,342
+179,948
+37% +$21.9M 2.22% 8
2014
Q3
$59.9M Buy
492,394
+345,354
+235% +$42M 1.54% 16
2014
Q2
$17.4M Buy
+147,040
New +$17.3M 0.43% 49

Other funds holding TMO

Banque Pictet & Cie's TMO Position: Q1 2026 in Review

Banque Pictet & Cie reduced its Thermo Fisher Scientific (TMO) stake by 38% in Q1 2026, selling an estimated $7.89M and leaving 23,986 shares worth $11.8M. The position accounts for 0.08% of the portfolio, ranked #91.

Banque Pictet & Cie first reported a position in TMO in Q2 2014 and has held it in 47 quarters since. The position peaked at $171M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Banque Pictet & Cie held 23,986 shares of Thermo Fisher Scientific worth $11.8M as of Q1 2026.
  • Banque Pictet & Cie sold 14,546 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.89M.
  • Thermo Fisher Scientific made up 0.08% of Banque Pictet & Cie's portfolio in Q1 2026, its #91 holding.
  • Banque Pictet & Cie first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 47 quarters since.
  • Banque Pictet & Cie's Thermo Fisher Scientific position peaked at $171M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.